ABL Bio Inc. (KOSDAQ:298380)

ABL Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	164,984	111,982	56,289	28,064	25,136	21,589
Short-Term Investments	-	2.58	80,852	8,026	7,611	74.38
Trading Asset Securities	2,099	2,960	4,371	35,075	45,570	22,058
Cash & Short-Term Investments	167,083	114,945	141,512	71,165	78,317	43,721
Cash Growth	21.20%	-18.77%	98.85%	-9.13%	79.13%	-
Accounts Receivable	0	59,112	-	-	-	-
Other Receivables	1.68	1.78	627.21	60.89	451.78	83.87
Receivables	1.68	59,114	827.21	260.89	451.78	83.87
Prepaid Expenses	-	1,483	1,416	1,779	819.53	563.08
Other Current Assets	2,785	508.77	396.07	2,333	946.34	1,105
Total Current Assets	169,870	176,051	144,151	75,539	80,535	45,472
Property, Plant & Equipment	100,350	101,142	85,406	76,035	6,713	3,304
Long-Term Investments	0	-0	-0	2,743	27,634	13,503
Other Intangible Assets	3,131	2,868	2,390	2,534	2,610	2,556
Other Long-Term Assets	372.93	873.57	27.99	3,294	67,689	617.29
Total Assets	273,724	280,934	231,976	160,144	185,181	65,453

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	2,552	462.2	397.73	165.07	131.53	15.98
Short-Term Debt	55,000	55,000	43,000	-	-	-
Current Portion of Leases	235.51	137.53	637.49	784.47	1,167	502.03
Other Current Liabilities	41,232	67,898	19,326	40,810	70,874	8,232
Total Current Liabilities	99,019	123,498	63,361	41,760	72,172	8,750
Long-Term Debt	-	-	-	43,000	40,000	-
Long-Term Leases	213.44	189.14	25.8	153.53	668.93	72.32
Pension & Post-Retirement Benefits	0	0	418.57	-	-	-
Other Long-Term Liabilities	549.97	549.97	890.74	1,152	2,826	677.05
Total Liabilities	99,782	124,237	64,696	86,065	115,667	9,500

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	27,994	27,563	24,141	23,946	23,894	23,562
Additional Paid-In Capital	590,258	544,959	510,998	363,760	361,173	348,732
Retained Earnings	-465,413	-436,216	-398,304	-342,345	-339,134	-342,535
Comprehensive Income & Other	18,629	18,414	27,556	28,718	23,580	26,194
Total Common Equity	171,468	154,719	164,391	74,079	69,513	55,953
Minority Interest	2,473	1,978	-	-	-	-
Shareholders' Equity	173,941	156,697	167,280	74,079	69,513	55,953
Total Liabilities & Equity	273,724	280,934	231,976	160,144	185,181	65,453

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	55,449	55,327	43,663	43,938	41,836	574.35
Net Cash (Debt)	111,635	59,618	97,849	27,227	36,481	43,147
Net Cash Growth	18.16%	-39.07%	259.38%	-25.37%	-15.45%	-
Net Cash Per Share	2022.71	1157.60	2037.61	569.08	766.95	918.60
Filing Date Shares Outstanding	55.99	55.13	48.28	47.89	47.79	47.12
Total Common Shares Outstanding	55.99	55.13	48.28	47.89	47.79	47.12
Working Capital	70,851	52,553	80,791	33,779	8,362	36,722
Book Value Per Share	3062.61	2806.69	3404.81	1546.78	1454.61	1187.37
Tangible Book Value	168,337	151,851	162,000	71,545	66,903	53,397
Tangible Book Value Per Share	3006.69	2754.66	3355.30	1493.87	1400.00	1133.14
Land	61,310	61,211	1,361	1,194	1,173	-
Buildings	27,966	28,872	1,361	1,194	1,173	-
Machinery	6,608	12,827	8,290	7,352	6,540	5,809
Construction In Progress	-	111.4	79,806	70,491	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error